Shuang Yang

No ORCID on file · 3 papers in corpus
rct 2026
Safety, pharmacokinetics, and sex hormone suppression of LY01021 versus relugolix: A single- and multiple-dose escalation study
European journal of pharmacology ·doi:10.1016/j.ejphar.2026.178639

BACKGROUND: LY01021 is a novel oral small-molecule gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of various sex hormone-dependent disorders. This study aimed to evaluate the safety, tolerability, pharm…

observational 2023
The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
Heliyon ·doi:10.1016/j.heliyon.2023.e18016

To evaluate the role of serum human epididymis secretory protein 4 (HE4) and carbohydrate antigen 125 (CA125) levels for predicting and monitoring the recurrence of endometrial endometrioid carcinoma (EEC) and assessing preoperative risk st…

other 2021
Expression and significance of miR-30d-5p and SOCS1 in patients with recurrent implantation failure during implantation window
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00820-2

BACKGROUND: Poor endometrial receptivity is a major factor that leads to recurrent implantation failure. However, the traditional method cannot accurately evaluate endometrial receptivity. Various studies have indicated that microRNAs (miRN…